IGC Gains on Word of Alzheimer’s Treatment

IGC Pharma, Inc. (NYSE:IGC) shares made small progress Wednesday, on word its ongoing Phase 2 trial for agitation in Alzheimer’s disease has been officially named CALMA (Calming Agitation in Alzheimer’s). The Potomac, Md.-based company says its trial’s new identity reflects its mission to address agitation, a syndrome affecting up to 76% of the 55 million…

Read More

Meta Platforms Ends Fact Checking On Social Media Platforms

Meta Platforms (META) has announced that it is ending a fact-checking program on its social media platforms such as Facebook that was meant to counter disinformation. Meta chief executive officer (CEO) Mark Zuckerberg said that the current fact-checking program will be replaced with a “community notes” system like the one found on X / Twitter….

Read More

Amazon To Spend $11 Billion On A.I. Infrastructure

E-commerce giant Amazon (AMZN) plans to spend $11 billion U.S. to expand its artificial intelligence (A.I.) infrastructure. Amazon says that it plans to invest heavily in Georgia to support cloud computing and A.I. technologies related to Amazon Web Services (AWS), its cloud computing unit. Amazon needs to develop data centers and advanced infrastructure to support…

Read More